NCT06748833

Brief Summary

The goal of this clinical trial is to utilize mobile-sensing techniques to produce and test a simplified and personalized treatment app, Smile for Life (SMILE), for youth diagnosed with an anxiety disorder. The main questions it aims to answer are:

  • Complete an online survey on emotional well-being and personality traits at the beginning and end of the one-month study, as well as at the 3-month follow-up. Participants will receive daily notifications asking participants to rate their social-emotional functioning. The app will then recommend a treatment plan and also ask participants to rate how helpful treatments were. Three months after the end of the study, participants will be asked to complete a follow-up assessment rating the app's usability.
  • Participants in the intervention group will use a mobile app to practice cognitive behavioural therapy (CBT) treatment for their social-emotional issues.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable anxiety

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 19, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 24, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 3, 2024

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

December 19, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 27, 2024

Completed
Last Updated

January 3, 2025

Status Verified

January 1, 2025

Enrollment Period

1 year

First QC Date

December 19, 2024

Last Update Submit

January 2, 2025

Conditions

Keywords

anxietysleep problemsyouthsmobile appsmobile sensingeHealth

Outcome Measures

Primary Outcomes (1)

  • Anxiety and sleep problems

    Anxiety symptoms will be assessed using the 41-item SCARED questionnaire, where participants rate symptoms as not/hardly ever true (1), somewhat/sometimes true (2), or very/often true (3). Sleep problems will be assessed with the 7-item ISI, measuring difficulty falling/staying asleep and waking too early on a 5-point scale (0 = none, 4 = very severe). The ISI also evaluates sleep satisfaction, the noticeability of sleep issues, worry/distress about sleep, and their impact on daily functioning. Both tools will be administered pre- and post-intervention and at a three-month follow-up, providing comprehensive data on changes in anxiety and sleep problems over time. These measures will help determine the intervention's effectiveness in reducing anxiety and improving sleep quality.

    One month

Study Arms (2)

SMILE Intervention Group

EXPERIMENTAL

The intervention group used the SMILE App, and the Predicting Risk and Outcomes of Social InTerActions (PROSIT) app, which is a mobile sensing app.

Behavioral: SMILE Intervention App

Control Non-SMILE Intervention Group

NO INTERVENTION

Participants in the control group downloaded and used only the PROSIT app, they did not use the SMILE App.

Interventions

The SMILE app, an iOS and Android compatible smartphone app, is based on effective CBT-based treatment features to help patients manage anxiety symptomology. Access requires a unique login. The SMILE app utilizes three relaxation features: calm breathing, mindfulness meditation, and deep muscle relaxation; one cognitive feature, thought journaling and the challenging of thoughts; one self-monitoring technique; a positive imagery game; and a feature aimed to reduce avoidance behaviour through exposure. The app will be self-guided, with no additional human involvement needed. Participants will be instructed to actively engage with at least one of the app's major functions for a minimum of 3 minutes per day.

SMILE Intervention Group

Eligibility Criteria

Age12 Years - 21 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Ability to read, write, and speak English
  • Aged 12-21
  • Regular access to and usage of a smartphone
  • Score \>25 on SCARED (25) (i.e., youth with anxiety disorders)

You may not qualify if:

  • Other psychotherapy-based intervention
  • Major medical illnesses which might impact participation (e.g., long periods of hospitalization)
  • Youth who cannot provide informed consent (as this is a self-directed treatment program).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dalhousie University

Halifax, Nova Scotia, B3H 4R2, Canada

Location

MeSH Terms

Conditions

Anxiety DisordersParasomnias

Condition Hierarchy (Ancestors)

Mental DisordersSleep Wake DisordersNervous System Diseases

Study Officials

  • Sandra M Meier, PhD

    Dalhousie University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 19, 2024

First Posted

December 27, 2024

Study Start

September 19, 2023

Primary Completion

September 24, 2024

Study Completion

December 3, 2024

Last Updated

January 3, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Participant data will be made available upon reasonable request to Dr. Sandra Meier (PI).

Locations